Neurogene Aktie
WKN DE: A3EX79 / ISIN: US64135M1053
10.05.2024 13:46:29
|
Neurogene Inc. Q1 Loss Beats Estimates
(RTTNews) - Neurogene Inc. (NGNE) reported Loss for first quarter that beat the Street estimates.
The company's bottom line came in at -$16.921 million, or -$1 per share. This compares with -$12.263 million, or -$28.28 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$1.13 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
Neurogene Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$16.921 Mln. vs. -$12.263 Mln. last year. -EPS (Q1): -$1 vs. -$28.28 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Neurogenemehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Neurogenemehr Analysen
Aktien in diesem Artikel
Neurogene | 14,94 | 1,98% |
|